PlainRecalls
FDA Drug Moderate Class II Terminated

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Reported: July 22, 2020 Initiated: June 29, 2020 #D-1387-2020

Product Description

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Reason for Recall

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
498 tablets
Distribution
Product was distributed to MN.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.. Recalled by RemedyRepack Inc.. Units affected: 498 tablets.
Why was this product recalled?
FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 22, 2020. Severity: Moderate. Recall number: D-1387-2020.